Philip Spanheimer (@pspanheimer) 's Twitter Profile
Philip Spanheimer

@pspanheimer

Surgeon-Scientist @UNC | Training: Iowa Surgery, MSKCC | Clinic: Breast Cancer, Sarcoma | NCI-funded Lab: molecular genetics, targeted therapeutics.

ID: 1047263353767440384

calendar_today02-10-2018 23:13:35

255 Tweet

551 Followers

444 Following

Philip Spanheimer (@pspanheimer) 's Twitter Profile Photo

Wonderful study demonstrating the safety of de-escalation in these low risk patients. Looking forward to results of the UNC Lineberger CAMERAN trial (Dana L. Casey) to determine if short course RT > ET for quality of life. patty spears @RyanMorseUNC Gaorav Gupta

Philip Spanheimer (@pspanheimer) 's Twitter Profile Photo

So proud of Gray Peery. Asked a question in clinic, designed a study and saw it through to publication. Does your scribe do that????? UNC School of Medicine 👀 out for her application!! Kristalyn Gallagher UNC Lineberger UNC Surgery Laura Burkbauer authors.elsevier.com/a/1hiKs578XeAOM

Adam C Palmer (@ac_palmer) 's Twitter Profile Photo

New paper: Most approved drug combinations for advanced cancer (1995-2020) have predictable clinical efficacy, because they have additive effect on Progression-Free Survival times. In Nature Cancer at rdcu.be/drhs0 by Haeun (Hannah) Hwangbo Sarah Patterson Deborah Plana, MD, PhD 1/6

New paper:

Most approved drug combinations for advanced cancer (1995-2020) have predictable clinical efficacy, because they have additive effect on Progression-Free Survival times.

In <a href="/NatureCancer/">Nature Cancer</a> at rdcu.be/drhs0

by <a href="/HaeunHwangbo/">Haeun (Hannah) Hwangbo</a> <a href="/SC_Patterson/">Sarah Patterson</a> <a href="/PlanaDeborah/">Deborah Plana, MD, PhD</a>
1/6
UNC Surgery (@uncsurgery) 's Twitter Profile Photo

Why do some patients with #breastcancer respond to treatment and some do not? Philip Spanheimer, MD and collaborators advance depth of exploration in how breast tumors become resistant to therapy: go.unc.edu/spanheimer Philip Spanheimer | UNC Lineberger | UNC School of Medicine

Why do some patients with #breastcancer respond to treatment and some do not?   
Philip Spanheimer, MD  and collaborators advance depth of exploration in how breast tumors become resistant to therapy:  go.unc.edu/spanheimer
<a href="/PSpanheimer/">Philip Spanheimer</a> | <a href="/UNC_Lineberger/">UNC Lineberger</a> | <a href="/UNC_SOM/">UNC School of Medicine</a>
The Breast Cancer Research Foundation (@bcrfcure) 's Twitter Profile Photo

While it’s very rare, male breast cancer can be more challenging to treat and has poorer outcomes compared to breast cancer in women. As we close out #MensHealthMonth, we highlight BCRF investigator Dr. Jose Pablo Leone, who seeks to address this. bit.ly/3RF8T2E